FAM188A Inhibitors
FAM188A inhibitors encompass a range of chemical compounds that target specific signaling pathways and cellular processes to indirectly hinder the functional activity of FAM188A. Rapamycin and its interaction with FKBP12 results in mTOR inhibition, which underlies a crucial mechanism for cell growth and protein synthesis. The inhibition of mTOR can lead to a cascade of effects that destabilizeFAM188A inhibitors encompass a range of chemical compounds that target specific signaling pathways and cellular processes to indirectly hinder the functional activity of FAM188A. Rapamycin and its interaction with FKBP12 results in mTOR inhibition, which underlies a crucial mechanism for cell growth and protein synthesis. The inhibition of mTOR can lead to a cascade of effects that destabilize various proteins, potentially including FAM188A, by reducing its stability and interference with its cellular functions. Similarly, Wortmannin and LY294002, as inhibitors of PI3K, and Triciribine, targeting Akt phosphorylation, disrupt upstream signaling events. This disruption can lead to a reduction in FAM188A activity by modulating downstream processes that could be essential for FAM188A's stability and function within the cell.
Further impacting the FAM188A landscape, compounds like PD98059 and U0126, which inhibit MEK1/2, and SP600125 and SB203580, targeting JNK and p38 MAP kinase respectively, impede the MAPK/ERK pathway. The inhibition of this pathway may result in reduced phosphorylation of proteins that interact with or regulate FAM188A, leading to its functional inhibition. Src family kinases, targeted by PP2 and Dasatinib, play a pivotal role in numerous signaling pathways that regulate protein turnover and function. Their inhibition can indirectly decrease FAM188A function or stability. Moreover, proteasome inhibitors like Bortezomib and MG132 disrupt the degradation of ubiquitinated proteins, potentially leading to the accumulation of misfolded or otherwise impaired proteins that may interact with or affect FAM188A function, further contributing to the decrease in its cellular activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and the resulting complex inhibits mTOR (mechanistic target of rapamycin), which is crucial for protein synthesis and cell growth. As mTOR signaling is essential for various cellular functions, its inhibition can lead to reduced protein stability, potentially affecting FAM188A's function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in signaling pathways that regulate cell growth and survival. By inhibiting PI3K, wortmannin can downregulate the Akt/mTOR pathway, potentially leading to decreased stability and function of FAM188A. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the phosphorylation and activation of Akt, which is downstream of PI3K. Akt inhibition disrupts many cellular processes, including those that may stabilize or facilitate the activity of FAM188A, thus leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that blocks the activation of the PI3K/Akt signaling pathway. Its action can lead to reduced phosphorylation of downstream targets, including those involved in the stability and function of FAM188A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which plays a role in the MAPK/ERK pathway. By inhibiting MEK, PD98059 can lead to decreased activation of ERK, a kinase that might be involved in phosphorylating proteins that interact with or regulate FAM188A's function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2, which are upstream regulators of the ERK pathway. Inhibition of this pathway by U0126 could result in reduced phosphorylation and activation of proteins that may be necessary for the proper function of FAM188A. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the stress-activated protein kinase pathway. Inhibition of JNK signaling can lead to alterations in cellular responses to stress, which may include modulation of the function or stability of FAM188A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. The p38 pathway is involved in cellular responses to cytokines and stress, and its inhibition could potentially alter the signaling events that affect the function of FAM188A. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Src kinases are involved in various signaling pathways that can regulate the turnover and function of proteins. Inhibiting Src kinases could indirectly lead to decreased function or stability of FAM188A. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a multi-targeted tyrosine kinase inhibitor, which includes Src family kinases. By inhibiting these kinases, dasatinib can interfere with multiple signaling pathways, potentially leading to a decrease in the functional activity or stability of FAM188A. | ||||||